Brief Report: Acamprosate in Fragile X Syndrome
- 6 March 2010
- journal article
- case report
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 40 (11) , 1412-1416
Abstract
Glutamatergic dysfunction is implicated in the pathophysiology of fragile X syndrome (FXS). We report on the first trial of acamprosate, a drug with putative mGluR5 antagonism, in three adults with FXS and autism. Medical records describing open-label treatment with acamprosate in 3 patients with FXS and a comorbid diagnosis of autistic disorder were reviewed. In all three patients, acamprosate was associated with improved linguistic communication. Three patients received acamprosate over a mean 21.3 weeks of treatment. All patients showed global clinical benefit as rated with the Clinical Global Impressions-Improvement scale. Marked communication improvement was unexpected and has potential implications for the treatment of FXS, as well as idiopathic autism.Keywords
This publication has 30 references indexed in Scilit:
- Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO miceNeurobiology of Disease, 2008
- The fragile X prevalence paradoxJournal of Medical Genetics, 2008
- Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actionsInternational Journal of Neuropsychopharmacology, 2008
- Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndromeThe Journal of Physiology, 2008
- Effects of Acamprosate on Neuronal Receptors and Ion Channels Expressed inXenopusOocytesAlcohol, Clinical and Experimental Research, 2008
- Correction of Fragile X Syndrome in MiceNeuron, 2007
- Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEPNeuropharmacology, 2005
- Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X SyndromeNeuron, 2005
- The mGluR theory of fragile X mental retardationTrends in Neurosciences, 2004
- Absence of expression of the FMR-1 gene in fragile X syndromeCell, 1991